CatenaBio
Berkeley, US · 3 known investors
Catena Biosciences develops therapeutics using its CysTyr conjugation platform to create Multi-Payload Conjugates (MPCs), a next-generation form of antibody-drug conjugate that delivers dual payloads. The company initially targets solid tumors with high unmet medical need.
Investors · 3
Frequently asked questions
- What does CatenaBio do?
- Catena Biosciences develops therapeutics using its CysTyr conjugation platform to create Multi-Payload Conjugates (MPCs), a next-generation form of antibody-drug conjugate that delivers dual payloads. The company initially targets solid tumors with high unmet medical need.
- Who are CatenaBio's investors?
- CatenaBio's investors include FREEFLOW, LongeVC, NYBC Ventures.
- Where is CatenaBio headquartered?
- CatenaBio is headquartered in Berkeley, US.